KRAS and adenocarcinoma: Compared to conventional adenocarcinoma, CNEC frequently exhibited BRAF mutations (59% vs. 5%) and less frequently displayed KRAS mutations (17% vs. 43%); the large majority (93%) of CNECs showed proficient mismatch repair [337].